Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply.
作者信息
Tan Anthony T, Le Bert Nina, Bertoletti Antonio
机构信息
Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore.
Singapore Immunology Network, A*STAR, Singapore.
出版信息
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI155701.
Abstract
摘要
相似文献
1
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply.合并基础疾病患者中新型冠状病毒2型特异性T细胞检测的敏感性差异。回复。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI155701.
2
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.患有基础疾病患者中新型冠状病毒2型特异性T细胞检测的敏感性差异。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI155499.
3
Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.评估 SARS-CoV-2 免疫在康复期儿童和青少年中的作用。
Front Immunol. 2021 Dec 17;12:797919. doi: 10.3389/fimmu.2021.797919. eCollection 2021.
4
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.在接受利妥昔单抗治疗的患者中接种 SARS-CoV-2 疫苗：B 细胞在 T 细胞介导的免疫存在下促进体液免疫反应。
Ann Rheum Dis. 2021 Oct;80(10):1345-1350. doi: 10.1136/annrheumdis-2021-220781. Epub 2021 Jul 20.
5
Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency.抗体缺陷患者对 SARS-CoV-2 的强大抗体和 T 细胞反应。
J Clin Immunol. 2021 Aug;41(6):1146-1153. doi: 10.1007/s10875-021-01046-y. Epub 2021 May 13.
6
SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort study.在非洲人群中，有和没有 HIV 的个体中的 SARS-CoV-2 特异性 T 细胞和体液免疫：一项前瞻性队列研究。
Int J Infect Dis. 2023 Feb;127:106-115. doi: 10.1016/j.ijid.2022.12.009. Epub 2022 Dec 11.
7
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
8
SARS-CoV-2-specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID-19 vaccination.在COVID-19疫苗接种后未产生血清转化的异基因造血干细胞移植受者中，不到一半的人产生了SARS-CoV-2特异性T细胞。
Eur J Immunol. 2022 Jul;52(7):1194-1197. doi: 10.1002/eji.202149771. Epub 2022 Apr 28.
9
Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan.体液免疫和 T 细胞应答对 SARS-CoV-2 的反应揭示了在巴基斯坦大流行早期期间的免疫情况。
BMC Infect Dis. 2023 Dec 1;23(1):846. doi: 10.1186/s12879-023-08829-1.
10
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays.评估针对 SARS-CoV-2 的体液免疫：蚀斑减少中和试验的验证和常规及替代中和测定法的多实验室比较。
Microbiol Spectr. 2021 Dec 22;9(3):e0088621. doi: 10.1128/Spectrum.00886-21. Epub 2021 Nov 17.
引用本文的文献
1
Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting.嵌合抗原受体修饰的 Bcl-2 对增强实体瘤靶向的协同效应。
Hum Cell. 2024 Sep;37(5):1421-1433. doi: 10.1007/s13577-024-01088-5. Epub 2024 Jun 15.
2
Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma.成人T细胞白血病/淋巴瘤发生过程中的病毒、遗传和免疫因素。
Int J Hematol. 2023 Apr;117(4):504-511. doi: 10.1007/s12185-023-03547-5. Epub 2023 Jan 27.
3
Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies.免疫调节治疗患者中，有利于诱导 SARS-CoV-2 特异性 T 细胞应答的特征。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI159500.
4
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.流式细胞术免疫分析与 QuantiFERON® SARS-CoV-2 试验在检测和定量 COVID-19 疫苗接种后 SARS-CoV-2 刺突反应性 IFN-γ 产生 T 细胞方面的性能比较。
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.
本文引用的文献
1
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions.患有基础疾病患者中新型冠状病毒2型特异性T细胞检测的敏感性差异。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI155499.
2
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals.从接种疫苗和自然感染个体的全血中快速测量 SARS-CoV-2 刺突 T 细胞。
J Clin Invest. 2021 Sep 1;131(17). doi: 10.1172/JCI152379.
3
SARS-CoV-2 infection generates tissue-localized immunological memory in humans.SARS-CoV-2 感染在人类中产生组织特异性免疫记忆。
Sci Immunol. 2021 Nov 19;6(65):eabl9105. doi: 10.1126/sciimmunol.abl9105.
4
Identification of resident memory CD8 T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue.鉴定未暴露的咽淋巴组织中针对 SARS-CoV-2 具有功能特异性的驻留记忆 CD8 T 细胞。
Sci Immunol. 2021 Oct 22;6(64):eabk0894. doi: 10.1126/sciimmunol.abk0894.
5
SARS-CoV-2-specific T cells in infection and vaccination.SARS-CoV-2 特异性 T 细胞在感染和接种疫苗中的作用。
Cell Mol Immunol. 2021 Oct;18(10):2307-2312. doi: 10.1038/s41423-021-00743-3. Epub 2021 Sep 1.
Zotero 插件